The global demand for Aripiprazole Drug Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026. Whereas with regards to volume, the market was calculated XX Kilo Tons in 2019 and foreseen to touch XX Kilo Tons by 2026 with a CAGR of XX% during 2020-2026.
Aripiprazole drug is an antipsychotic drug recommended in combination to treat mental/mood disorders such as bipolar disorder, Tourette's syndrome, schizophrenia, and irritability associated with autistic disorder. The drug works by decreasing hallucinations and improving concentration. It helps to reinstitute the balance of natural chemicals in the brain. It can also treat mood swings. Aripiprazole drug is typically indicated orally but also directed as an injection. It is sold under brand names Abilify, Aristada, Abilify Maintena, and Abilify MyCite.
Rising prevalence of mental disorders and growing FDA approvals for new treatments drive the growth of the market. The burden of mental disorders is growing continuously with significant impacts on health and major social, economic consequences in all countries. Around 450 million people presently suffer from mental disorders, placing among the leading causes of ill-health and disability. Given the significant burden of suffering, there will be increased demand for Aripiprazole drugs. However, low awareness among people hinders the growth of the market. About 66% of individuals with a realized mental issue never look for help from a health professional. To address this, various awareness program is being implemented, which is predicted to eradicate the market hindrance.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of aripiprazole drug.
The entire aripiprazole drug market has been sub-categorized into type and applications. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Orally Disintegrating Tablets
- Oral Solution
- Adult Patients
- Pediatric Patients
This section covers regional segmentation which accentuates on current and future demand for aripiprazole drug market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Aripiprazole Drug Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aripiprazole drug market include Otsuka Pharmaceutical, Teva, APOTEX, Barr Laboratories, Sun Pharmaceutical, Alembic Pharmaceuticals, Orchid Pharma, Amneal, Aurobindo Pharma, Lannett. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.